FIELD: pharmaceutics.
SUBSTANCE: invention relates to pharmaceutics. Disclosed is a pharmaceutical composition for treating breast cancer based on doxorubicin in a phospholipid matrix with particle size of 10–20 nm, comprising a plant-derived phospholipid with phosphatidylcholine content of not less than 95 %, doxorubicin hydrochloride and maltose, with the following ratio of components, wt%: doxorubicin hydrochloride – 0.9–1.1; phospholipid – 18–22; maltose monohydrate 76.9–81.1.
EFFECT: reduced toxicity of the composition as a whole with preservation of its therapeutic effectiveness, reduced manifestation of palmar-plantar syndrome in the patients receiving chemotherapeutic treatment, reduced cost of the therapeutic course.
1 cl, 5 ex, 8 tbl, 9 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION BASED ON DOXORUBICINE AND PHOSPHOLIPID NANOPARTICLES FOR TREATMENT OF ONCOLOGIC DISEASES | 2009 |
|
RU2411935C1 |
| METHOD OF COMBINED THERAPY FOR CONNECTIVE TISSUE SARCOMA M-1 IN RATS USING A CONJUGATE OF DIPROPOXYBACTERIOPURPURIN WITH DOXORUBICIN | 2023 |
|
RU2808909C1 |
| AGENT AND METHOD FOR TREATMENT AND PROPHYLAXIS OF ONCOLOGY DISEASES | 2005 |
|
RU2283658C1 |
| SPECIFIC COMBINED THERAPY OF MALIGNANT TUMOURS WITH CYTOSTATIC AGENT AND ITS MODIFYING AGENT | 2015 |
|
RU2571551C1 |
| LIPID DERIVATIVE OF SARCOLYSIN IN THE COMPOSITION OF PHOSPHOLIPID NANOPARTICLES | 2017 |
|
RU2662086C1 |
| HIGHLY EFFECTIVE METHOD FOR PREPARING DOSAGE FORM OF TARGETED ACTION FOR THERAPY OF MALIGNANT GROWTHS | 2019 |
|
RU2727924C1 |
| BASED ON BOTANICAL PHOSPHOLIPIDS NANOSYSTEM FOR ACTUATION OF BIOLOGICALLY ACTIVE COMPOUNDS, AND METHOD OF ITS MANUFACTURE (VERSIONS) | 2009 |
|
RU2391966C1 |
| DOXORUBICIN AND ORGANOSILICON NANOPARTICLES-NIOSOMES- BASED PHARMACEUTICAL GEL FOR SKIN CANCER TREATING | 2014 |
|
RU2600164C2 |
| METHOD FOR PREPARING PHOSPHOLIPID NANOPARTICLE ENCLOSED CHLORINE E6 COMPOSITION FOR PHOTODYNAMIC THERAPY | 2013 |
|
RU2535054C1 |
| PHARMACEUTICAL NIOSOMAL GEL BASED ON N-HYDROXY-2-(2-(NAPHTALENE-2-YL)-1H-INDOLE-3-YL)-2-PHENYLACETAMIDE WITH ANTI-TUMOUR ACTIVITY TO GLIOBLASTOMA | 2015 |
|
RU2627449C2 |
